In this online CME self-learning program:
There are a multitude of strategies a healthcare organization may adopt to improve its surgical quality standards, chief among them enhanced recovery pathways (ERPs) or enhanced recovery after surgery (ERAS) practices, which encompass myriad components. These components include a variety of what have traditionally been interspersed into different areas of specialty: antisepsis and infection control, patient warming, glucose control, multimodal pain control, nausea control, fluid and nutrition therapy, and many others, not to mention ensuring that all of these aspects continue uninterrupted while the patient transitions throughout all levels of care. These pathways are designed to attenuate the stress response during a patient’s surgical procedure and preserve organ function while promoting early recovery. While this approach is not new, it has not always been widely employed in spite of supporting evidence from a range of randomized controlled trials, systematic reviews, and meta-analyses. This literature suggests that ERAS programs are safe, cost-effective, and minimize the length of stay in a hospital without compromising quality of care. ERAS programs are successful in part because they are proactive in nature, comprised of interventions beginning during preoperative planning and continuing through intraoperative management and postoperative care.
Dr. Monty Mythen shares his experiences in the United Kingdom, what the United States and the rest of the world has begun to adopt, and where we still have left to go.
This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is supported by Educational Grants from Edwards Lifesciences.
Release Date: September 12, 2015 -- Expiration Date: September 12, 2017
Faculty: Monty Mythen, MD
By the end of the session the participant will be able to:
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved through content review ScientiaCME.
Dr. Monty Mythen, MD discloses that he is a consultant / speaker for Edwards Lifesciences and Deltex.
Disclosures of Educational Planner: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC, which has received a grant from the commercial supporter of this program: Edwards Lifesciences .
Commercial Support Disclosure: This program is supported by an educational grant from Edwards Lifesciences
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.